FrancophonIA/ELRC3.0 huggingface dataset:
English: Oropharyngeal pain
Slovenian: Okvara ledvic
English: Malignancy
Slovenian: Malvern
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM EUSA Pharma
English: Siltuximab is a chimeric (human-murine) immunoglobulin G1κ (IgG1κ) monoclonal antibody produced in a Chinese hamster ovary (CHO) cell line by recombinant DNA technology.
Slovenian: Situksimab je himerni (človeško-glodalski) imunoglobulin G1κ (IgG1κ).
English: From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbial contamination, the product should be used immediately.
Slovenian: Iz mikrobiološkega vidika je pripravljeno zdravilo treba porabiti takoj, razen če je bilo zdravilo odprto/pripravljeno in razredčeno v aseptičnih pogojih.
English: Table 3: Efficacy endpoints from study 1 Efficacy endpoints
Slovenian: Preglednica 3: Cilji opazovanja za oceno učinkovitosti v študiji 1 Cilji opazovanja za oceno učinkovitosti siltuksimab + BSC*
English: Signs of such a tear developing include stomach pain getting worse, feeling sick (nausea), change in bowel habits and fever - if you get any of these, contact your doctor right away.
Slovenian: Znaki pojava raztrganine so poslabšanje želodčnih bolečin, siljenje na bruhanje (navzea), spremembe odvajanja blata in zvišana telesna temperatura.
English: Sucrose
Slovenian: Barnahely
English: Haemoglobin increase > 15 g/L (0.9 mmol/L) at Week 13/haemoglobin response-evaluable population
Slovenian: zvečanje koncentracije hemoglobina na > 15 g/l (0,9 mmol/l) po 13 tednih pri populaciji s podatkom o koncentraciji hemoglobina trajanje tumorskega in simptomatskega odziva
English: Immune system disorders common
Slovenian: Bolezni imunskega sistema pogosti anafilaktična reakcija
English: Histidine hydrochloride monohydrate Polysorbate 80
Slovenian: FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi histidin histidinijev klorid monohidrat polisorbat 80 saharoza
English: Data from all patients treated with siltuximab monotherapy (n = 370) form the overall basis of the safety evaluation.
Slovenian: Skupna baza podatkov za oceno varnosti zdravila vsebuje podatke vseh bolnikov, ki so prejemali siltuksimab v monoterapiji (n = 370).
English: SYLVANT 100 mg powder for concentrate SYLVANT 400 mg powder forconcentrate siltuximab
Slovenian: SYLVANT 100 mg prašek za koncentrat SYLVANT 400 mg prašek za koncentrat siltuksimab i.v.
English: SYLVANT 400 mg powder for concentrate for solution for infusion Each single-use vial contains 400 mg siltuximab powder for concentrate for solution for infusion.
Slovenian: SYLVANT 400 mg prašek za koncentrat za raztopino za infundiranje Ena viala za enkratno uporabo vsebuje 400 mg siltuksimaba v obliki praška za koncentrat za raztopino za infundiranje.
English: Hypertension
Slovenian: Dojenje
English: A statistically significant difference (61.3% vs. 0% respectively; p = 0.0002) in the haemoglobin response in the siltuximab arm compared with the placebo arm was observed.
Slovenian: Med skupino, ki je prejemala siltuximab in skupino, ki je prejemala placebo so opazili statistično značilno razliko v hemoglobinskem odzivu (61,3% v primerjavi z 0%; p = 0,0002).
English: Biomarkers
Slovenian: Biološki označevalci
English: A consistent treatment effect favouring siltuximab treated patients across all major secondary endpoints was shown in the hyaline vascular subgroup.
Slovenian: Izjema je bila podskupina s hialino vaskularnim histološkim podtipom v kateri v skupini s siltuksimabom noben bolnik ni dosegel primarnega cilja opazovanja V podskupini s hialino vaskularnim histološkim podtipom, ki je prejemala siltuksimab je analiza v vseh glavnih sekundarnih ciljih opazovanja pokazala enoten boljši učinek zdravljenja.
English: Hypercholesterolaemia
Slovenian: Bolezni jeter
English: • joint pain, arm or leg pain
Slovenian: • glavobol • bolečina v sklepih, rokah ali nogah
English: methods.
Slovenian: Sylvant.
English: Durable tumour & symptomatic response (independent review)
Slovenian: Primarni cilj za oceno učinkovitosti trajni tumorski in simptomatski odziv (po oceni neodvisnih ocenjevalcev)
English: Each single-use vial contains 400 mg siltuximab.
Slovenian: Ena viala za enkratno uporabo vsebuje 400 mg siltuksimaba.
English: Inspect the vials for particulate matter and discolouration prior to dose preparation.
Slovenian: Pred pripravljanjem odmerka preglejte viale, da ne vsebujejo trdnih delcev in njihova vsebina ni obarvana.
English: This medicinal product should be administered by qualified healthcare professionals and under appropriate medical supervision.
Slovenian: 4.2 Odmerjanje in način uporabe Zdravilo lahko daje usposobljen zdravstveni delavec.
English: Subgroup analyses
Slovenian: KLINIČNI PODATKI
English: Each vial contains 100 mg of siltuximab.
Slovenian: Ena viala vsebuje 100 mg siltuksimaba.
English: Each single-use vial contains 100 mg siltuximab.
Slovenian: Ena viala za enkratno uporabo vsebuje 100 mg siltuksimaba.
English: Cross-study population PK analyses were performed using data from 378 patients with a variety of conditions who received single-agent siltuximab at doses ranging from 0.9 to 15 mg/kg.
Slovenian: Vsi bolniki so prejemali siltuksimab kot edino zdravilo v odmerkih od 0,9 do 15 mg/kg.
English: Vascular disorders very common
Slovenian: Žilne bolezni zelo pogosti hipertenzija
English: Each vial contains 400 mg of siltuximab.
Slovenian: Ena viala vsebuje 400 mg siltuksimaba.
English: SYLVANT 100 mg powder for concentrate for solution for infusion SYLVANT 400 mg powder for concentrate for solution for infusion siltuximab
Slovenian: SYLVANT 100 mg prašek za koncentrat za raztopino za infundiranje SYLVANT 400 mg prašek za koncentrat za raztopino za infundiranje siltuksimab
English: SYLVANT 100 mg powder for concentrate for solution for infusion SYLVANT 400 mg powder for concentrate for solution for infusion
Slovenian: SYLVANT 100 mg prašek za koncentrat za raztopino za infundiranje SYLVANT 400 mg prašek za koncentrat za raztopino za infundiranje
English: If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist, or nurse before you are given SYLVANT.
Slovenian: Če karkoli od zgoraj navedenega velja za vas (tudi če o tem niste prepričani), se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, preden prejmete zdravilo SYLVANT.
English: • weight gain.
Slovenian: največja vrednost)
English: Hypertriglyceridaemia, hyperuricaemia common
Slovenian: Presnovne in prehranske motnje zelo pogosti hipertrigliceridemija, hiperurikemija pogosti hiperholesterolemija
English: ≥ 50 x 109/L
Slovenian: ≥ 50 x 109/l hemoglobina
English: - Keep this leaflet.
Slovenian: Nežno premešajte.
English: Table 2 reflects the frequencies of identified adverse reactions in the 87 MCD patients (Study 1, Study 2 and Study 3) treated at the recommended dosage of 11 mg/kg every 3 weeks (details provided in section 5.1).
Slovenian: Bolniki so prejemali priporočeni odmerek 11 mg/kg vsake 3 tedne (podrobnosti so navedene v poglavju 5.1).
English: No evidence of altered safety or efficacy was identified in the patients who developed antibodies to siltuximab.
Slovenian: Pri bolnikih s protitelesi proti siltuksimabu niso odkrili sprememb v varnosti ali učinkovitosti.
English: Tell your doctor straight away if you notice the following side effects, as he or she may need to stop your treatment:
Slovenian: Drugi neželeni učinki so lahko: Če opazite katerega od naslednjih neželenih učinkov se pogovorite z zdravnikom ali medicinsko sestro:
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Slovenian: B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le na posebni recept.
English: Infections and infestations very common
Slovenian: Bolezni sečil zelo pogosti okvara ledvic
English: The following factors had no clinical effect on the clearance of siltuximab: gender, age, and ethnicity.
Slovenian: Spol, starost in etnična pripadnost nimajo kliničnega učinka na očistek siltuksimaba.
English: (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8)
Slovenian: Zdravilo SYLVANT je indicirano za zdravljenje odraslih bolnikov z multicentrično Castlemanovo boleznijo (MCD - multicentric Castleman's disease), ki niso okuženi z virusom humane imunske pomanjkljivosti (so HIV negativni) in niso okuženi s humanim herpesvirusom-8 (so HHV-8
English: Elderly
Slovenian: VIALA
English: Do not use if visibly opaque or if foreign particles and/or solution discolouration are present.
Slovenian: Če vsebina ni prozorna ali je obarvana in/ali če vsebuje tujke, je ne smete uporabiti.
English: Each vial should be reconstituted with 5.2 mL of single-use water for injections to yield a 20 mg/mL solution.
Slovenian: Eno vialo je treba rekonstituirati s 5,2 ml vode za injekcije za enkratno uporabo, da nastane raztopina z
English: In mice dosed subcutaneously with an anti-mouse IL-6 monoclonal antibody,
Slovenian: Pri miših, ki so jim subkutano dajali monoklonsko protitelo proti mišjemu IL-6, niso opazili vpliva na plodnost niti pri samcih niti pri samicah.
English: • rash, itchy skin rash (eczema)
Slovenian: • izpuščaj, srbeč kožni izpuščaj (ekcem)
English: During or following infusion, treatment should be discontinued in patients who have severe infusion related hypersensitivity reactions (e.g., anaphylaxis).
Slovenian: Pri bolnikih, ki imajo hudo preobčutljivostno reakcijo na infuzijo (npr. anafilaksijo), je treba odmerjanje zdravila SYLVANT ukiniti med infundiranjem ali po njem.
English: Talk to your doctor, pharmacist, or nurse before you are given SYLVANT if:
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila SYLVANT, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro: • če imate trenutno kakšno okužbo - zdravilo SYLVANT lahko zmanjša vaše zaznavanje, da ste okuženi, oziroma obrambno sposobnost v primeru okužbe in lahko pride do poslabšanja okužbe
English: 3 years
Slovenian: Zaprta viala 3 leta
English: This summary was last updated in April 2015.
Slovenian: Povzetek je bil nazadnje posodobljen aprila 2015.
English: Most of these dogs also received additional treatment.
Slovenian: Večina teh psov je bila deležna tudi dodatnega zdravljenja.
English: Other information about Cerenia:
Slovenian: Druge informacije o zdravilu Cerenia:
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Cerenia on 29/09/2006.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Cerenia, veljavno po vsej Evropski uniji, izdala 29. septembra 2006.
English: Maropitant
Slovenian: Cerenia maropitant
English: Cerenia is a medicine that contains the active substance maropitant.
Slovenian: Cerenia je zdravilo, ki vsebuje zdravilno učinkovino maropitant.
English: Information on the prescription status of this product can be found on the label/outer package.
Slovenian: Podatki o predpisovanju tega zdravila so navedeni na nalepki/zunanji ovojnini.
English: A large number of studies with Cerenia were carried out either in laboratory dogs and cats or in animal patients at veterinary practices in several European countries and in the USA.
Slovenian: Z zdravilom Cerenia so bile opravljene številne študije, bodisi na laboratorijskih psih in mačkah bodisi na bolnih živalih v veterinarskih ordinacijah v številnih evropskih državah in ZDA.
English: Other reported side effects were decreased activity levels and tiredness.
Slovenian: Drugi neželeni učinki, o katerih so poročali, so bili zmanjšana telesna aktivnost in utrujenost.
English: What benefit has Cerenia shown during the studies?
Slovenian: Kakšne koristi je zdravilo Cerenia izkazalo v študijah?
English: It is available as tablets (16, 24, 60 and 160 mg) for dogs, and as a solution for injection (10 mg/ml) under the skin or into a vein for dogs and cats.
Slovenian: Na voljo je v obliki tablet (16, 24, 60 in 160 mg) za pse in kot raztopina za injiciranje v podkožje ali v žilo (10 mg/ml) za pse in mačke.
English: Handling Cerenia does not represent a particular risk for people.However, maropitant can produce short lived eye irritation and in the case of accidental eye exposure, the eyes should be flushed with plenty of water and medical attention sought.
Slovenian: Dajanje zdravila Cerenia ne predstavlja posebnega tveganja za ljudi, vendar lahko maropitant povzroči kratkotrajno draženje oči.V primeru nenamernega izpostavljanja oči zdravilu jih je treba sprati z veliko vode in poiskati zdravniško pomoč.
English: Only one out of 16 dogs given Cerenia vomited after receiving morphine, whilst 14 out of 15 dogs given placebo vomited, and in this group, nine of the dogs that vomited did so more than once.
Slovenian: Samo eden od 16 psov, ki so prejeli zdravilo Cerenia, je bruhal, potem ko so mu dali morfin, od 15 psov, ki so prejeli placebo, pa jih je bruhalo 14, pri čemer je v tej skupini devet psov bruhalo več kot enkrat.
English: The measures of effectiveness were evidence of retching, vomiting, intensity of nausea and improvements in the speed of recovery by for example measuring time to sit up and stand.
Slovenian: Merila učinkovitosti so bili znaki siljenja na bruhanje, bruhanje, intenzivnost slabosti in hitrejše okrevanje, ki so ga na primer merili s časom, ki so ga psi potrebovali, da so se usedli ali vstali.
English: Also, the treatment of vomiting should only be together with other supportive measures or other veterinary therapy while addressing the underlying causes of the vomiting.
Slovenian: Zdravljenje bruhanja je treba poleg tega izvajati samo skupaj z drugimi podpornimi ukrepi ali drugim veterinarskim zdravljenjem, pri čemer se je treba posvetiti izvirnim vzrokom bruhanja.
English: The benefit-risk balance can be found in the scientific discussion module of this EPAR.
Slovenian: Razmerje med koristmi in tveganji je na voljo v modulu znanstvene razprave tega evropskega javnega poročila o oceni zdravila (EPAR).
English: Cerenia was generally well tolerated.
Slovenian: Zdravilo Cerenia so živali na splošno dobro prenašale.
English: Why has Cerenia been approved?
Slovenian: Zakaj je bilo zdravilo Cerenia odobreno?
English: What is the risk associated with Cerenia?
Slovenian: Kakšna tveganja so povezana z uporabo zdravila Cerenia?
English: Since maropitant could affect heart activity, Cerenia should be used with caution in animals with certain heart conditions.
Slovenian: Ker bi maropitant lahko vplival na delovanje srca, je treba pri živalih, ki imajo nekatera srčna obolenja, zdravilo uporabljati previdno.
English: The active substance in Cerenia, maropitant, is broken down in the liver and therefore it is recommended to be used with caution in animals with liver disease.
Slovenian: Zdravilna učinkovina v zdravilu Cerenia, maropitant, se razgrajuje v jetrih, zato je priporočljivo, da se pri živalih z obolenji jeter uporablja previdno.
English: Since this was mainly observed in dogs with an empty stomach, it is recommended to feed a light meal or snack a while before the tablets are given.
Slovenian: Ker so ta učinek opazili predvsem pri psih, ki so tableto dobili na prazen želodec, je priporočljivo, da živali pred prejetjem tablete zaužijejo lahek obrok ali prigrizek.
English: A very common side effect in cats was evidence of pain from injection under the skin and this may be reduced by injection of the product at refrigerated temperature.
Slovenian: Zelo pogost neželeni učinek pri mačkah so bile bolečine med injiciranjem v podkožje, kar je mogoče zmanjšati z injiciranjem ohlajenega zdravila.
English: the animal owner can administer the tablets to the dog.
Slovenian: Za nadaljevanje zdravljenja lahko lastnik psu daje tablete.
English: For dogs, the treatment of vomiting should be started with the injection, since vomiting animals might throw the intact tablet up again.
Slovenian: Zdravljenje bruhanja pri psih je treba začeti z injekcijo, ker bi psi, ki bruhajo, utegnili ponovno izbruhati celo tableto.
English: The CVMP concluded that the benefits of Cerenia exceed its risks and recommended that Cerenia be given a marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila Cerenia večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
English: In the study looking at the effect of Cerenia before and after surgery, Cerenia was effective at preventing vomiting asociated with the use of morphine.
Slovenian: V študiji, v kateri so proučevali učinek zdravila Cerenia pred kirurškim posegom in po njem, je bilo zdravilo učinkovito pri preprečevanju bruhanja, povezanega z uporabo morfina.
English: The bioequivalence studies showed that giving the injection under the skin produced the same levels of maropitant in the body as giving the injection into a vein.
Slovenian: Študije biološke enakovrednosti so pokazale, da je z injiciranjem v podkožje raven maropitanta v telesu enaka kot z injiciranjem v veno.
English: A common side effect of the tablets when used at a high dose of 8 mg/kg in dogs (for motion sickness) was vomiting before the car journey started.
Slovenian: Pogost neželeni učinek tablet, kadar so se uporabljale v visokem odmerku 8 mg/kg pri psih (za preprečevanje slabosti zaradi vožnje), je bilo bruhanje pred začetkom vožnje z avtomobilom.
English: In case of accidental ingestion or self-injection medical advice should be sought immediately and the package leaflet or the label shown to the physician.
Slovenian: V primeru nenamernega zaužitja ali samoinjiciranja zdravila se je treba nemudoma posvetovati z zdravnikom in mu pokazati navodilo za uporabo zdravila ali nalepko.
English: Dogs received either Cerenia soluton for injection or placebo 45 minutes before the administration of morphine for sedation and pain relief prior to anaesthesia .
Slovenian: Psi so prejeli bodisi zdravilo Cerenia v obliki raztopine za injiciranje bodisi placebo 45 minut preden so prejeli morfin za sedacijo in lajšanje bolečin pred anestezijo.
English: In dogs the tablets can be used to prevent vomiting due to motion sickness.
Slovenian: Pri psih se lahko tablete uporabljajo za preprečevanje bruhanja zaradi potovalne slabosti.
English: What is Cerenia used for?
Slovenian: Za kaj se zdravilo Cerenia uporablja?
English: Since Cerenia has not been studied in very young dogs or cats, or in pregnant or lactating bitches or queens, use of Cerenia in these animals should be discussed with your veterinarian.
Slovenian: Ker zdravila niso proučevali pri zelo mladih psih ali mačkah niti pri brejih oziroma doječih psicah in mačkah, se je treba o njegovi uporabi v teh primerih posvetovati z veterinarjem.
English: In cats, treatment of vomiting is with the injection only.
Slovenian: Zdravljenje bruhanja pri mačkah je mogoče samo z injekcijo.
English: In cats the solution for injection is used to prevent vomiting and to reduce nausea, but is not suitable for motion (travel) sickness.
Slovenian: Pri mačkah se raztopina za injiciranje uporablja za preprečevanje bruhanja in lajšanje slabosti, ni pa primerna za potovalno slabost.
English: In order to study the effect of Cerenia in motion sickness, dogs prone to vomiting when travelling were taken on car journeys lasting several hours for up to two consecutive days.
Slovenian: Da bi proučili učinek zdravila Cerenia pri slabosti zaradi vožnje, so pse, ki so bili nagnjeni k bruhanju med potovanji, peljali na večurno vožnjo z avtomobilom največ dva dneva zapored.
English: Cerenia solution for injection is used in dogs both to prevent nausea and vomiting before and after an operation and to improve recovery from general anaesthesia after use of morphine.
Slovenian: Pri psih se raztopina za injiciranje uporablja za preprečevanje slabosti in bruhanja pred operacijo in po njej ter za hitrejše okrevanje po splošni anesteziji, pri kateri je bil uporabljen morfin.
English: Bioequivalence studies were conducted in both dogs and cats to compare giving the injection under the skin with injection into a vein.
Slovenian: Pri psih in mačkah so bile izvedene študije biološke enakovrednosti, da bi primerjali injiciranje v podkožje z injiciranjem v veno.
English: A further study involving dogs looked at the prevention of nausea and vomiting before and after surgery.
Slovenian: V dodatni študiji pri psih, so proučevali preprečevanje slabosti in bruhanja pred operacijo in po njej.
English: For the treatment of vomiting, the effect of Cerenia compared with placebo was examined in sick cats that were vomiting for various reasons.
Slovenian: Za zdravljenje bruhanja so učinke zdravila v primerjavi s placebom proučevali na bolnih mačkah, ki so bruhale iz različnih razlogov.
English: What is Cerenia?
Slovenian: Kaj je zdravilo Cerenia?
English: For the prevention of vomiting, Cerenia was studied in cats which received either Cerenia or placebo before another substance known to trigger vomiting was given to them.
Slovenian: Za preprečevanje bruhanja so zdravilo Cerenia proučevali pri mačkah, ki so prejele bodisi zdravilo Cerenia bodisi placebo, preden so jim dali kakšno drugo snov, za katero je znano, da povzroča bruhanje.
English: How has Cerenia been studied?
Slovenian: Kako je bilo zdravilo Cerenia raziskano?
English: As injection under the skin causes pain in cats, the animal will need to be restrained when treated.
Slovenian: Ker so za mačke injekcije v podkožje boleče, jih je treba med zdravljenjem imobilizirati.
English: For the prevention of vomiting, Cerenia was studied in dogs which received either Cerenia or a placebo (a dummy tablet or injection) before another substance known to trigger vomiting (such as certain cancer medicines) was given to them.
Slovenian: Za preprečevanje bruhanja so zdravilo Cerenia proučevali pri psih, ki so prejeli bodisi zdravilo Cerenia bodisi placebo (tableto ali injekcijo brez zdravilne učinkovine), preden so jim dali kakšno drugo snov, za katero je znano, da povzroča bruhanje (na primer nekatera zdravila proti raku).
English: How does Cerenia work?
Slovenian: Kako zdravilo Cerenia deluje?
English: For the treatment of vomiting, the effect of Cerenia (or a placebo) was examined in sick dogs that were vomiting for various reasons, for example because of a gastrointestinal infection.
Slovenian: Učinek zdravila Cerenia (ali placeba) za zdravljenje bruhanja so proučevali pri bolnih psih, ki so bruhali iz različnih razlogov, na primer zaradi okužbe prebavil.
English: Dogs were treated with either 1 mg/kg (injection given under the skin) or 2 mg/kg (tablet) once daily up to five days.
Slovenian: Pse so zdravili z odmerki 1 mg/kg (z injekcijami v podkožje) ali 2 mg/kg (s tabletami) enkrat dnevno za največ pet dni.
English: Cerenia is used to prevent (tablets and solution for injection) and treat (solution for injecton) nausea caused by chemotherapy in dogs.
Slovenian: Zdravilo Cerenia se uporablja za preprečevanje (s tabletami in raztopino) ali zdravljenje slabosti (z raztopino) zaradi kemoterapije pri psih.
English: Cats were treated with 1 mg/kg (injection given under the skin) once daily up to five days.
Slovenian: Mačkam so dajali zdravilo v odmerku 1 mg/kg (z injekcijo) enkrat dnevno do pet dni.
English: Cerenia tablets are given to dogs at a dose of 8 mg maropitant per kg bodyweight once daily to prevent vomiting due to motion sickness for a maximum of two consecutive days.
Slovenian: Tablete zdravila Cerenia se psom dajejo enkrat na dan za največ dva dni zapored v odmerku 8 mg maropitanta na kg telesne mase za preprečevanje bruhanja zaradi vožnje.
English: Cerenia solution for injection is given to dogs and cats once daily under the skin or into a vein (1 mg per kg bodyweight) for up to five days.
Slovenian: Zdravilo Cerenia se v obliki raztopine psom in mačkam injicira v podkožje enkrat na dan (1 ml na kg telesne mase) za največ pet dni.